DHA (Omega-3)
DHA is essential for brain development and maintenance, but RCT results are mixed. A 2012 Cochrane review (n=4,080) found no cognitive benefit of omega-3 supplements in cognitively healthy older adults, and a 2025 meta-analysis found no meaningful ADAS-Cog benefit once Alzheimer's has developed. Two 6-month RCTs were positive: 900mg DHA/day improved learning and recognition memory in age-related cognitive decline (Yurko-Mauro et al., 2010 — sponsored by the algal-DHA maker Martek, with a Martek employee as lead author), and 1.16g/day improved memory and working-memory reaction times in healthy adults aged 18–45 with low DHA intake (Stonehouse 2013). A 2021 NIH-funded meta-analysis (n=81,210) found omega-3 supplements raise atrial fibrillation risk, more so above 1g/day.
Evidence reviewed:
Mechanism of action
Docosahexaenoic acid (DHA) is the primary structural omega-3 fatty acid in the brain, constituting ~40% of polyunsaturated fatty acids in neuronal membranes. DHA maintains membrane fluidity, enabling proper receptor function, ion channel activity, and synaptic vesicle dynamics. It also resolves neuroinflammation via specialised pro-resolving mediators (SPMs) and supports BDNF (brain-derived neurotrophic factor) expression for neuroplasticity.
Clinical evidence summary
DHA is essential for brain development and maintenance, but RCT results are mixed. A 2012 Cochrane review (n=4,080) found no cognitive benefit of omega-3 supplements in cognitively healthy older adults, and a 2025 meta-analysis found no meaningful ADAS-Cog benefit once Alzheimer's has developed. Two 6-month RCTs were positive: 900mg DHA/day improved learning and recognition memory in age-related cognitive decline (Yurko-Mauro et al., 2010 — sponsored by the algal-DHA maker Martek, with a Martek employee as lead author), and 1.16g/day improved memory and working-memory reaction times in healthy adults aged 18–45 with low DHA intake (Stonehouse 2013). A 2021 NIH-funded meta-analysis (n=81,210) found omega-3 supplements raise atrial fibrillation risk, more so above 1g/day.
Human effect matrix
Based on human clinical trials only. Animal and in-vitro data excluded.
| Effect | Evidence | Magnitude | Studies |
|---|---|---|---|
| Memory (Age-Related Decline) | moderate | Moderate | 1 |
| Memory (Healthy Adults) | moderate | Moderate | 1 |
| Mood & Depression | moderate | Small | — |
| Brain Structure Preservation | moderate | Moderate | — |
Evidence key: Strong = multiple consistent RCTs · Moderate = smaller/fewer RCTs · Preliminary = early trials or small n · Mixed = conflicting results
Documented benefits
- Learning and recognition memory in age-related cognitive decline (900mg/day)
- Memory and reaction time in healthy adults with low DHA intake (1.16g/day)
- Neuronal membrane integrity
Side effects & cautions
- Atrial fibrillation: a 2021 meta-analysis of cardiovascular RCTs (PMID 34612056, n=81,210) found omega-3 supplements raised atrial fibrillation risk (HR 1.25), rising to HR 1.49 at more than 1g/day — talk to your doctor if you have heart-rhythm problems
- Fishy aftertaste or burps
- Mild GI problems (under 15% of participants in the Cochrane review, similar to placebo)
- Potential blood-thinning effect at very high doses (>3g/day)
How to take
Stacking recommendations
Ingredients that pair well with DHA (Omega-3) and why.
DHA provides the structural fat for membranes; PS is the phospholipid that organises membrane architecture. Together they provide comprehensive neuronal membrane support.
DHA maintains membrane integrity while Lion's Mane stimulates NGF for neuroplasticity. Foundational + growth-oriented brain support.
Citicoline provides choline for membrane phospholipid synthesis; DHA provides the fatty acid substrate. Together they supply the raw materials for brain cell membrane repair.
Frequently asked questions
DHA vs EPA — which matters more for brain health?
DHA is the structural omega-3 in brain membranes (~40% of brain PUFA), making it more directly relevant to cognitive function. EPA is more potent as an anti-inflammatory and shows stronger effects for mood/depression. For brain health, prioritise DHA — the positive cognitive trials used 900mg–1.16g DHA per day. For mood support, prioritise EPA. Most quality supplements provide both; keep the atrial fibrillation signal above 1g/day of total omega-3 in mind.
Can I get enough DHA from diet alone?
If you eat fatty fish (salmon, mackerel, sardines) 2-3 times per week, you likely get sufficient DHA. Most people in Western diets consume far below optimal levels. Vegetarians and vegans are particularly at risk for deficiency — algal DHA supplements are the solution. A blood test (Omega-3 Index) can measure your actual status.
Is fish oil or algal oil better?
DHA is the same molecule from either source. Algal oil avoids mercury/heavy metal concerns and is suitable for vegetarians. Fish oil provides a natural DHA+EPA ratio. No head-to-head trial has compared them on cognitive outcomes — choose based on dietary preference and quality of the specific product.
How long before I notice cognitive effects?
DHA works by rebuilding membrane composition, which is a slow process. Both positive cognitive RCTs ran for 24 weeks (6 months). You will not feel an acute effect like caffeine or L-theanine. Think of DHA as a long-term infrastructure investment, not a performance supplement.
Top stacks containing DHA (Omega-3)
DHA (Omega-3) in Japan
Products in Japan
Consumer Affairs Agency (FFC)
Regulatory note
本ページは教育目的の編集コンテンツであり、医学的助言を構成するものではありません。日本国内で販売される機能性表示食品（FFC）および特定保健用食品（FOSHU）は、消費者庁への届出または許可を必要とします。届出のない輸入品については、日本の薬機法（旧薬事法）の下で疾病治療を示唆する表現は規制されます。サプリメントを開始する前に、必ず資格のある医療専門家にご相談ください。This page is editorial and not medical advice. Foods with Function Claims (FFC) and Foods for Specified Health Uses (FOSHU) sold in Japan require notification or approval from the Consumer Affairs Agency. Imported products without notification cannot make disease-treatment claims under the Pharmaceuticals and Medical Devices (PMD) Act. Consult a qualified healthcare professional before starting any supplement.
Sources (6)expand
- PMID 20434961Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. (2010)
- PMID 23515006DHA supplementation improved both memory and reaction time in healthy young adults: a randomized controlled trial. (2013)
- PMID 22696350Omega 3 fatty acid for the prevention of cognitive decline and dementia. (2012)
- PMID 34612056Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. (2021)
- PMID 39991006Cognitive efficacy of omega-3 fatty acids in Alzheimer's disease: A systematic review and meta-analysis. (2025)
- PMID 26265727A High Omega-3 Fatty Acid Multinutrient Supplement Benefits Cognition and Mobility in Older Women: A Randomized, Double-blind, Placebo-controlled Pilot Study. (2015)